MD Anderson oncologist Stephen Hahn confirmed as FDA commissioner
The Senate voted 72-18 Thursday to confirm Hahn, a radiation oncologist and chief medical executive at The University of Texas MD Anderson Cancer Center.
Trump nominates MD Anderson oncologist as next FDA chief
HHS announced that it had nominated Dr. Stephen Hahn as the next FDA commissioner. Acting Commissioner Ned Sharpless will return to the National Cancer Institute, while HHS official Brett Giroir will temporarily step in pending Hahn's confirmation.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Report: Trump set to tap MD Anderson’s Hahn as FDA commissioner next week
Dr. Stephen Hahn, a radiation oncologist and MD Anderson's chief medical executive, has reportedly been in the running since September to succeed former FDA Commissioner Scott Gottlieb and current acting commissioner Ned Sharpless.
Report: Trump on track to nominate MD Anderson’s Dr. Stephen Hahn as FDA commissioner
BioCentury reported that the the nomination of radiation oncologist Dr. Stephen Hahn, who had been under consideration, would follow an FBI background check. Acting Commissioner Ned Sharpless and Brett Giroir, an assistant HHS secretary, had also reportedly been in the running.
Report: MD Anderson oncologist is under consideration for FDA post
Trump is reportedly considering Dr. Stephen Hahn to head the FDA. Others reportedly under consideration include acting Commissioner Ned Sharpless and HHS assistant secretary Brett Giroir.
Boehringer Ingelheim, MD Anderson to develop cancer drugs under research partnership
The two organizations are placing particular emphasis on lung and gastrointestinal cancers, as well as drug targets like KRAS mutations.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Judge rules MD Anderson must pay $4.3M for HIPAA violations
The violations date back to three separate breach reports in 2012 and 2013, which involve the stealing of an unencrypted laptop and the loss of two unencrypted USB thumb drives.
These healthcare leaders resigned this year amid tumult at their organizations
We're not six months into 2017 yet. But already, a number of healthcare leaders have turned in their resignation letters due to significant problems at their organizations.
At the intersection of cancer treatment and technology, it’s more evolution than revolution
In its first year at SXSW, a series of conversations around the topic of cancer, Connect to End Cancer, spurred some interesting discussion around telemedicine, advice for startups and the role of 5g technology to improve patient-physician encounters.
SonarMed trying to gather $2.5M in 2015 for endotracheal tube device advancement
Indianapolis-based SonarMed continues to move forward with perfecting and providing its non-invasive, adjunctive device that provides real-time monitoring of endotracheal tube position and function, originally developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.